Imidocarb dipropionate therapy in Kenyan anaplasmosis and babesiosis.
D000372:Agglutination Tests; D000709:Anaplasma / Q000276:immunology / Q000302:isolation & purification; D000712:Anaplasmosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001403:Babesia / Q000276:immunology / Q000302:isolation & purification; D001404:Babesiosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D001769:Blood / Q000382:microbiology; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D003168:Complement Fixation Tests; D005260:Female; D006400:Hematocrit; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007630:Kenya; D008297:Male; D013156:Splenectomy
D000900:Anti-Bacterial Agents